Business Description
Cocrystal Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US19188J3005
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 10.19 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.09 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -2.1 | |||||
3-Year EPS without NRI Growth Rate | -1.7 | |||||
3-Year FCF Growth Rate | 11.2 | |||||
3-Year Book Growth Rate | -33.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | -7.25 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 93.33 | |||||
9-Day RSI | 83.25 | |||||
14-Day RSI | 73.26 | |||||
6-1 Month Momentum % | 14.71 | |||||
12-1 Month Momentum % | -8.77 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.41 | |||||
Quick Ratio | 7.41 | |||||
Cash Ratio | 6.84 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -20.1 | |||||
Shareholder Yield % | -5.34 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -68.05 | |||||
ROA % | -60.46 | |||||
ROIC % | -937.09 | |||||
ROC (Joel Greenblatt) % | -1388.78 | |||||
ROCE % | -78.1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.21 | |||||
Price-to-Tangible-Book | 1.21 | |||||
EV-to-EBIT | -0.22 | |||||
EV-to-EBITDA | -0.22 | |||||
EV-to-FCF | -0.33 | |||||
Price-to-Net-Current-Asset-Value | 1.36 | |||||
Price-to-Net-Cash | 1.52 | |||||
Earnings Yield (Greenblatt) % | -454.55 | |||||
FCF Yield % | -67.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Cocrystal Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.638 | ||
Beta | 0.58 | ||
Volatility % | 61.85 | ||
14-Day RSI | 73.26 | ||
14-Day ATR (€) | 0.075 | ||
20-Day SMA (€) | 1.581 | ||
12-1 Month Momentum % | -8.77 | ||
52-Week Range (€) | 1.24 - 2.6 | ||
Shares Outstanding (Mil) | 10.17 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cocrystal Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cocrystal Pharma Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Cocrystal Pharma Inc Frequently Asked Questions
What is Cocrystal Pharma Inc(STU:8CC)'s stock price today?
When is next earnings date of Cocrystal Pharma Inc(STU:8CC)?
Does Cocrystal Pharma Inc(STU:8CC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |